MM

Investor profile

Matthew Miessau

Venture capital & Principal at Epidarex Capital

Matthew Miessau works as a Principal at Epidarex Capital. The firm's known portfolio counts 11 companies.

Is Matthew Miessau a fit for your startup?

Paste your website. AI checks the fit and scores every other investor too.

Investment focus

Contacts

mat***@***.comPhone number on fileLinkedIn profile on fileAvailable after registration.
Get contact

Affiliated funds' portfolios

Principal at Epidarex Capital, whose known portfolio counts 11 companies

  • Epsilogen
  • Theolytics
  • Harness Therapeutics
  • Nyra Medical
  • Ryme Medical
  • AdoRx Therapeutics
  • Curve Therapeutics
  • Leucid Bio
  • Mironid
  • Enterprise Therapeutics
  • Libra Therapeutics

Investor Profile

The listing covers sectors Hardware and Healthcare, and focus areas Biotech, Chemical, Drug Discovery and Genetics. Startups operating in these areas may find Matthew Miessau relevant.

Stage-wise, the deals at Epidarex Capital cluster around Seed, Series A and Series B rounds.

What the affiliated firm has backed is the closest available signal on whether Matthew Miessau is worth approaching.

Colleagues at Epidarex Capital

Frequently asked questions

Who is Matthew Miessau?

Matthew Miessau is a venture capital investor based in Washington, District of Columbia, United States, listed as Principal at Epidarex Capital. The known portfolio of that firm counts 11 companies. That portfolio belongs to the firm, not to Matthew Miessau personally.

What does Matthew Miessau invest in?

Listed sectors include Hardware and Healthcare; listed focus areas include Biotech, Chemical, Drug Discovery and Genetics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.

What stage does Matthew Miessau invest at?

Epidarex Capital appears in Seed, Series A and Series B rounds across its known deals, and Matthew Miessau is listed there as Principal. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.

Which firm is Matthew Miessau listed at?

Matthew Miessau is listed as Principal at Epidarex Capital. 4 other people in the database share a firm with Matthew Miessau.

How do I contact Matthew Miessau?

An email address, a phone number and a LinkedIn page are on file for Matthew Miessau. The address stays masked on this page and is readable inside RaiseHunt after you create an account.

Skip the browsing. Let AI find your ideal investors in one minute.

Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.

Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal